• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

The role of vitamin D in glycaemic control

Krul-Poel, Y.H.M.

2017

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Krul-Poel, Y. H. M. (2017). The role of vitamin D in glycaemic control.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

TABLE OF CONTENTS

General Introduction 9

Part I Gestational diabetes 19

Chapter 1 Vitamin D and Gestational Diabetes Mellitus: a systematic review and

meta-analysis 22

Part II PCOS 31

Chapter 2 The role of vitamin D in metabolic disturbances in polycystic ovary

syndrome (PCOS): a systematic review 32 Chapter 3 The association between vitamin D and metabolic disturbances in polycystic

ovary syndrome (PCOS): a cross-sectional study 55

Part III Type 2 Diabetes 71

Chapter 4 Study protocol: A randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2

Diabetes Mellitus (SUNNY trial) 75

Chapter 5 Effect of vitamin D supplementation on glycemic control in patients with Type 2 Diabetes (SUNNY trial): A Randomised Placebo-Controlled Trial 87 Chapter 6 Vitamin D status and health-related quality of life in patients with

Type 2 Diabetes 101

Chapter 7 Effect of vitamin D supplementation on health-related quality of life in patients with type 2 diabetes mellitus: a randomised double-blind

placebo-controlled trial 115

Chapter 8 Vitamin D status is associated with skin autofluorescence in patients with type 2 diabetes mellitus: a preliminary report 131 Chapter 9 The effect of vitamin D supplementation on glycaemic control in patients

(3)

PART IV: GENERAL DISCUSSION AND SUMMARY 165

General discussion 166

Summary 173

Nederlandse samenvatting 175

Dankwoord 178

About the author 181

Referenties

GERELATEERDE DOCUMENTEN

The aim of this study was to test whether six months of vitamin D supplementation improves the Short Form 36 (SF-36) Health Survey domain scores, especially the domains’

To conclude, the present study will evaluate the effects of a group-based, peer support intervention led by a peer leader and group psychotherapist on diabetes-related

In second- ary care, diabetes nurse specialists failed to recognise and document high levels of anxiety, depression or diabetes- specific emotional distress in approximately 75%

We included randomised controlled trials (RCT) in the following groups: vitamin D supplementation versus placebo, vitamin D supplementation and calcium supplementation versus

and Vitamin B12 levels We assessed the effects of Vitamin Supplementation on plasma homocysteme levels m 89 patients with a history of recurrent venous thrombosis and 227

Children from a mother with serum 25(OH)D concentrations of > 75 nmol/L during pregnancy had an increased risk of asthma at nine years of age, reported Gale et

To safely start vitamin K supplementation in patients receiving oral anticoagulants, it is important to know the effect of low doses of vitamin K on the INR and on the dose of

Physicians in primary and secondary care practices of the intervention group received an advisory message in the EMR during diabetes consulta- tions if patients were treated in